News (30)

Update
DateNews
May 4, 2017Business Wire - Poxel Announces First Quarter 2017 Financial Update
Apr 25, 2017Business Wire - Poxel Announces Appointment of Anne Renevot as Chief Financial Officer
Apr 3, 2017Business Wire - Poxel Reports Results for Fiscal Year 2016 and Provides Corporate Update
Mar 7, 2017Business Wire - Poxel Announces Appointment of Christophe Arbet-Engels, MD, PhD, MBA, as Chief Medical Officer and EVP Late Development & Medical Affairs, Based in Boston
Jan 27, 2017Business Wire - Poxel Announces Fourth Quarter 2016 Financial Update
Nov 9, 2016Business Wire - Poxel Announces Participation in Two Upcoming Investor Conferences
Oct 21, 2016Business Wire - Poxel Announces Third Quarter 2016 Financial Results and Corporate Update
Sep 15, 2016Business Wire - Poxel Presents New Data on Imeglimin and PXL770 at the European Association for the Study of Diabetes Annual Meeting
Sep 12, 2016Business Wire - Poxel Reports Results for First Half 2016 and Provides Corporate Update
Jul 26, 2016Business Wire - Poxel Announces Publication of Important New Mechanism Data for Imeglimin Relating to Insulin Secretion in the Treatment of Type 2 Diabetes
Jul 20, 2016Fierce Biotech - Postponing Nasdaq IPO, Poxel raises €26.5M to move diabetes drug into PhIII
Jul 19, 2016Business Wire - Poxel Closes a €26.5 Million Capital Increase
Jun 20, 2016Business Wire - Poxel Announces Positive Results From the First Stage of the Ongoing PXL770 Phase 1 Trial
Jun 7, 2016betapage.co - Ploxel is the white label solution for selling tickets for your event online.
Apr 18, 2016Business Wire - Poxel Announces Election of Pierre Legault as Chairman of the Board of Directors
Apr 1, 2016Business Wire - Poxel Reports Results for Fiscal Year 2015 and Provides Corporate Update
Dec 14, 2015Business Wire - Poxel Announces Imeglimin Phase 2b Initiation in Japan
Nov 23, 2015Business Wire - Poxel Presents New Data on Imeglimin and PXL770 at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Diseases in Los Angeles
Nov 23, 2015Business Wire - Poxel Presents New Data on Imeglimin and PXL770 at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Diseases in Los Angeles
Oct 22, 2015Business Wire - Poxel Reports Cash Position, Financial Results for the Third Quarter 2015 and Provides Corporate Update